PKC inhibitor reversed the suppressive effect of orexin-A on IPSCs of locus coeruleus neurons in naloxone-induced morphine withdrawal

J Neural Transm (Vienna). 2019 Nov;126(11):1425-1435. doi: 10.1007/s00702-019-02064-2. Epub 2019 Sep 6.

Abstract

The locus coeruleus (LC) as a target of addictive drugs receives a dense projection of orexinergic fibres from the lateral hypothalamus (LH) and is accordingly a candidate site for the expression of the somatic aspects of morphine withdrawal. Recently it has been shown that the inhibitory synaptic currents of LC neurons decrease partly through orexin type 1 receptors in the context of naloxone-induced morphine withdrawal; however, its cellular mechanism remains unclear. In this study, whole-cell patch clamp recordings of LC neurons in brainstem slices were used to investigate the impact of protein kinase C (PKC) on GABAergic inhibitory post-synaptic currents (IPSCs) in the context of naloxone-induced morphine withdrawal. Male Wistar rats (P14-P21) received morphine (20 mg/kg, i.p.) daily for 7 consecutive days to induce morphine dependency. Our results showed that the application of PKC inhibitor (Go 6983; 1 µM) alone did not decrease the probability of GABA release in the LC neurons of the morphine-treated rats in the presence of naloxone. Although, Go 6983 reversed the reduction of the amplitude of evoked IPSCs (eIPSCs) and spontaneous IPSCs (sIPSCs) frequency induced by orexin-A but did not change the sIPSCs amplitude. These results indicate that the suppressive effect of orexin-A on IPSCs is probably reversed by PKC inhibitor in the LC neurons of morphine-treated rats in the context of naloxone withdrawal.

Keywords: GABAA-IPSCs; Locus coeruleus; Naloxone-induced morphine withdrawal; Orexin type 1 receptor; PKC inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Indoles / pharmacology
  • Inhibitory Postsynaptic Potentials / drug effects*
  • Locus Coeruleus* / drug effects
  • Locus Coeruleus* / metabolism
  • Male
  • Maleimides / pharmacology
  • Morphine / administration & dosage
  • Morphine Dependence* / metabolism
  • Naloxone / pharmacology*
  • Narcotic Antagonists / pharmacology*
  • Narcotics / administration & dosage
  • Neurons / drug effects
  • Neurons / metabolism
  • Orexins / metabolism*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism*
  • Protein Kinase Inhibitors / pharmacology*
  • Rats
  • Rats, Wistar
  • Substance Withdrawal Syndrome* / metabolism
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide
  • Indoles
  • Maleimides
  • Narcotic Antagonists
  • Narcotics
  • Orexins
  • Protein Kinase Inhibitors
  • Naloxone
  • gamma-Aminobutyric Acid
  • Morphine
  • Protein Kinase C